Financials
- Market Capitalization 19.01 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.7
ratio cours/chiffre d'affaires
-66.55
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4579 | SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -1.61% | -12.86% | -12.86% | -23.75% | 21.44 M USD | ||
| 4599 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.62 USD | -0.38% | -6.43% | +11.49% | -16.56% | 20.94 M USD | ||
| 4606 | NXTC NextCure, Inc. - Common Stock | 6.58 USD | 0.00% | +269.66% | +219.42% | -49.77% | 23.77 M USD | ||
| 4608 | KALA KALA BIO, Inc. - Common Stock | 1.02 USD | +6.25% | -26.62% | -61.94% | -81.62% | 18.96 M USD |